Status:
TERMINATED
A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup
Lead Sponsor:
Medacta International SA
Conditions:
Osteoarthritis
Arthritis
Eligibility:
All Genders
Brief Summary
This is a multi-centre, prospective post marketing surveillance study to assess mid-term performance of the Mpact cup in subjects requiring primary total hip arthroplasty.
Eligibility Criteria
Inclusion
- Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery.
- Those presenting with disease that meets the indications for use for Medacta USA implants defined by this study (on-label use).
- Patients must be willing to comply with the pre and post-operative evaluation schedule.
Exclusion
- Those with one or more medical conditions identified as a contraindication defined by the labeling on any Medacta implants used in this study.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02196818
Start Date
March 1 2013
End Date
April 1 2022
Last Update
March 22 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Vail Orthopedics, P.C.
Denver, Colorado, United States, 80230
2
Saint Alphonsus Regional Medical Center
Boise, Idaho, United States, 83702
3
Illinois Bone & Joint Institute, LLC
Libertyville, Illinois, United States, 60048
4
Jordan Valley Medical Center
West Jordan, Utah, United States, 84088